Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.96 USD | -3.97% | -14.55% | -17.60% |
Apr. 17 | Exact Sciences Corporation announced that it has received $266.75 million in funding | CI |
Apr. 15 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
Financials (USD)
Sales 2024 * | 2.83B | Sales 2025 * | 3.23B | Capitalization | 11.52B |
---|---|---|---|---|---|
Net income 2024 * | -160M | Net income 2025 * | 6M | EV / Sales 2024 * | 4.6 x |
Net Debt 2024 * | 1.5B | Net Debt 2025 * | 1.08B | EV / Sales 2025 * | 3.91 x |
P/E ratio 2024 * |
-72.4
x | P/E ratio 2025 * |
2,209
x | Employees | 6,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.99% |
Latest transcript on Exact Sciences Corporation
1 day | -3.97% | ||
1 week | -6.72% | ||
Current month | -11.73% | ||
1 month | -2.71% | ||
3 months | -7.65% | ||
6 months | -5.12% | ||
Current year | -17.60% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Paul Limburg
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-05 |
Jorge Garces
CTO | Chief Tech/Sci/R&D Officer | 52 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Coward
BRD | Director/Board Member | 59 | 14-12-31 |
Kevin Conroy
CEO | Chief Executive Officer | 58 | 09-03-17 |
Freda Lewis-Hall
BRD | Director/Board Member | 68 | 20-04-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.80% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 60.96 | -3.97% | 2,168,241 |
24-04-18 | 63.48 | +0.41% | 1,597,962 |
24-04-17 | 63.22 | -1.00% | 2,516,226 |
24-04-16 | 63.86 | -2.28% | 3,472,199 |
24-04-15 | 65.35 | -8.40% | 3,060,358 |
Delayed Quote Nasdaq, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.60% | 11.52B | |
+39.11% | 3.27B | |
-20.67% | 2.02B | |
-29.30% | 1.44B | |
+11.45% | 1.01B | |
-6.33% | 719M | |
-30.75% | 418M | |
-51.02% | 339M | |
-2.58% | 284M | |
+25.57% | 240M |
- Stock Market
- Equities
- EXAS Stock